Provided by Tiger Fintech (Singapore) Pte. Ltd.

Phathom Pharmaceuticals

8.35
-0.1900-2.22%
Post-market: 8.31-0.0400-0.48%18:47 EDT
Volume:501.93K
Turnover:4.20M
Market Cap:581.56M
PE:-1.61
High:8.50
Open:8.40
Low:8.18
Close:8.54
Loading ...

Phathom Pharmaceuticals Secures FDA Approval for 10-Year Regulatory Exclusivity for VOQUEZNA® Tablets

Reuters
·
07 Jun

Director’s Bold Move: Phathom Pharmaceuticals Stock Purchase

TIPRANKS
·
24 May

Director James N. Topper Reports Acquisition of Common Shares in Phathom Pharmaceuticals Inc

Reuters
·
24 May

Phathom Pharmaceuticals Inc. Set to Participate in Goldman Sachs Annual Global Healthcare Conference 2025

Reuters
·
15 May

Director James N. Topper Reports Acquisition of Common Shares in Phathom Pharmaceuticals Inc

Reuters
·
14 May

Director Asit Parikh Reports Acquisition of Phathom Pharmaceuticals Common Shares

Reuters
·
09 May

Phathom Pharmaceuticals Is Maintained at Neutral by Goldman Sachs

Dow Jones
·
03 May

Phathom Pharmaceuticals Is Maintained at Buy by HC Wainwright & Co.

Dow Jones
·
02 May

Phathom Pharmaceuticals Reports Q1 2025 Financial Results

TIPRANKS
·
02 May

Phathom Pharmaceuticals Eyes Profitability Amid Growth

TIPRANKS
·
02 May

Phathom Pharmaceuticals Inc. Announces New Compensation Plan with Inducement Awards for Senior VP Jonathan Bentley

Reuters
·
02 May

Phathom Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire
·
02 May

BUZZ-U.S. STOCKS ON THE MOVE-Nvidia, Wayfair, Moderna

Reuters
·
02 May

Positive Outlook for Phathom Pharmaceuticals Amid Cost-Cutting and Regulatory Catalysts

TIPRANKS
·
02 May

Phathom Pharmaceuticals Inc reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
01 May

Phathom Pharmaceuticals, Inc. (PHAT) Reports Q1 Loss, Tops Revenue Estimates

Zacks
·
01 May

UPDATE: Phathom Pharmaceuticals Q1 Adj. EPS $(1.07) Beats $(1.15) Estimate,

Benzinga
·
01 May

Phathom Pharmaceuticals reports Q1 EPS ($1.07), consensus ($1.07)

TIPRANKS
·
01 May

BRIEF-Phathom Pharmaceuticals Q1 Net Income USD -94.316 Million

Reuters
·
01 May

Phathom Pharmaceuticals Reports First Quarter 2025 Financial Results and Provides Business Update

GlobeNewswire
·
01 May